<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">26700622</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>11</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1949-2553</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Jan</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncotarget</Title>
                <ISOAbbreviation>Oncotarget</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3905-20</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.6678</ELocationID>
            <Abstract>
                <AbstractText>Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular matrix (ECM), and its over expression in human prostate cancer has been associated with disease progression, androgen independence and metastatic ability. Nevertheless, the pathophysiology of OPN in prostate tumorigenesis has never been studied. We crossed TRansgenic Adenocarcinoma of the Mouse Prostate (TRAMP) mice with OPN deficient (OPN-/-) mice and followed tumor onset and progression in these double mutants. Ultrasound examination detected the early onset of a rapidly growing, homogeneous and spherical tumor in about 60% of OPN-/- TRAMP mice. Such neoplasms seldom occurred in parental TRAMP mice otherwise prone to adenocarcinomas and were characterized for being androgen receptor negative, highly proliferative and endowed with neuroendocrine (NE) features. Gene expression profiling showed up-regulation of genes involved in tumor progression, cell cycle and neuronal differentiation in OPN-deficient versus wild type TRAMP tumors. Down-regulated genes included key genes of TGFa pathway, including SMAD3 and Filamin, which were confirmed at the protein level. Furthermore, NE genes and particularly those characterizing early prostatic lesions of OPN-deficient mice were found to correlate with those of human prostate NE tumours. These data underscore a novel role of OPN in the early stages of prostate cancer growth, protecting against the development of aggressive NE tumors.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mauri</LastName>
                    <ForeName>Giorgio</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jachetti</LastName>
                    <ForeName>Elena</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Comuzzi</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dugo</LastName>
                    <ForeName>Matteo</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Functional Genomics and Bioinformatics, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arioli</LastName>
                    <ForeName>Ivano</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miotti</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sangaletti</LastName>
                    <ForeName>Sabina</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Carlo</LastName>
                    <ForeName>Emma</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Aging, Section of Anatomic Pathology and Molecular Medicine, &quot;G. d'Annunzio&quot; University, 66100, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Ce.S.I. Aging Research Center, &quot;G. d'Annunzio&quot; University Foundation, 66100, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tripodo</LastName>
                    <ForeName>Claudio</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tumor Immunology Unit, Department of Health Sciences, University of Palermo, 90127, Palermo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Colombo</LastName>
                    <ForeName>Mario P</ForeName>
                    <Initials>MP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133, Milano, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Oncotarget</MedlineTA>
            <NlmUniqueID>101532965</NlmUniqueID>
            <ISSNLinking>1949-2553</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>106441-73-0</RegistryNumber>
                <NameOfSubstance UI="D053495">Osteopontin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017353" MajorTopicYN="Y">Gene Deletion</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018358" MajorTopicYN="N">Neuroendocrine Tumors</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053495" MajorTopicYN="N">Osteopontin</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">extracellular matrix</Keyword>
            <Keyword MajorTopicYN="N">neuroendocrine</Keyword>
            <Keyword MajorTopicYN="N">osteopontin</Keyword>
            <Keyword MajorTopicYN="N">prostate cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>11</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2015</Year>
                <Month>11</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>12</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>12</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26700622</ArticleId>
            <ArticleId IdType="pii">6678</ArticleId>
            <ArticleId IdType="doi">10.18632/oncotarget.6678</ArticleId>
            <ArticleId IdType="pmc">PMC4826179</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2009 Sep 1;69(17):7096-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19706764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prostate Cancer Prostatic Dis. 2012 Jun;15(2):150-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22343836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16199517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 1994 Sep;145(3):610-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8080043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2010;5(11):e13984</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21085593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Res. 2013 Oct;11(10):1203-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23851444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Oncol. 2014 Mar 25;4:60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24724054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2008 Nov 15;14(22):7470-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19010864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2014 Sep 1;74(17):4706-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25035397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Ther Targets. 2014 Aug;18(8):883-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24899149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biol. 2005 Jul 4;170(1):81-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15983059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2009 Oct 1;28(39):3487-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19597474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 1999 Aug;5(8):2271-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10473115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Differentiation. 2002 Dec;70(9-10):506-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12492493</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Jul 15;65(14):6337-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16024636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 2007 Jan;38(1):161-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16997353</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2008 Jul 25;134(2):215-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18662538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2012 Aug 21;107(5):840-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22871886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2004 Mar 15;64(6):2270-305</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15026373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2009 Jul 2;114(1):49-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19417209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):595-600</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19155438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neoplasia. 2007 Nov;9(11):938-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18030362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 1994 Dec;18(12):1240-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7977947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stem Cells Transl Med. 2013 Sep;2(9):678-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23884639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2007 Aug;7(8):621-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17611544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian J Androl. 2009 May;11(3):291-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19398956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2001 May 25;276(21):17871-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11278410</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2006 Feb 15;118(4):850-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16108038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3439-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7724580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Appl Genet Mol Biol. 2004;3:Article3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16646809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prostate Cancer Prostatic Dis. 2008;11(1):32-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17984999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2014 Feb;35(2):452-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24067903</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer. 2007;6:38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17553164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2012 Feb 1;18(3):666-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22156612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Endocrinol. 1994 Feb;8(2):230-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8170479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2002 Nov-Dec;22(6C):3819-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12553000</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prostate Cancer Prostatic Dis. 2008;11(4):377-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18379588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Aug 5;351(6):552-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15295048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1986 Dec 25;315(26):1650-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3537791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Urol. 2009 Jan;16(1):37-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19120524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Cancer Prev. 2012;13(5):1943-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22901151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2008 Jul 1;24(13):1547-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18467348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prostate. 2005 Mar 1;62(4):322-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15389779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013;8(4):e61848</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23620793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1997 Nov 1;57(21):4687-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9354422</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2005 Jun 6;201(11):1781-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15928197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2007 Jul 15;67(14):6925-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17638904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 2008 Jan;172(1):236-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18156212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2009 Sep;29(17):4623-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19564413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24399786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prostate. 2005 Aug 1;64(3):224-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15712212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Metastasis Rev. 2010 Jun;29(2):295-307</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20386958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Cell. 2005 Oct;16(10):4672-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16093355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2007 May 1;13(9):2784-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17473212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Discov. 2011 Nov;1(6):487-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22389870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochemistry. 1979 Nov 27;18(24):5294-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">518835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2001;12 Suppl 2:S135-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11762341</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>